| Jun 30, 2026 | 11% | supported by testing utilization gains, including benefits from recent product launches and net new customer growth with 11% expansion of the IDEXX global premium instrument installed base and net price gains. 8-K filed 2026-08-04 |
|---|
| Mar 31, 2026 | 12% | supported by testing utilization gains, including increasing benefit from recent product launches, 12% growth in IDEXX's global premium instrument installed base, and net price gains. 8-K filed 2026-05-05 |
|---|
| Dec 31, 2025 | 12% | IDEXX VetLab™ consumables generated 17% revenue growth as reported and 15% organically, led by recent product launches, 12% global premium instrument installed base growth, and testing utilization expansion. 8-K filed 2026-02-02 |
|---|
| Sep 30, 2025 | 10% | IDEXX VetLab™ consumables generated 18% reported and 16% organic revenue growth, supported by testing utilization gains, including increasing benefit from recent product launches, and 10% growth in IDEXX's global premium instrument installed base. 8-K filed 2025-11-03 |
|---|
| Jun 30, 2025 | 10% | IDEXX VetLab® consumables generated 15% reported and 14% organic revenue growth, with testing utilization gains across regions, benefits from recent product launches, and 10% growth in IDEXX's global premium instrument installed base. 8-K filed 2025-08-04 |
|---|